Regenerative Medicine

〒550-0014 STAR HILLS, 1-3-13 Kitahorie, Nishi-ku, Osaka

診療時間

TEL06-6543-1500

What is regenerative medicine?

Regenerative medicine is a field that harnesses the innate regenerative power inherent in all individuals to pioneer new treatment pathways alongside patients for diseases that were previously considered difficult to treat. Using advanced treatment methods, it aims for fundamental improvement of diseases and is also gaining attention as “treatment that restores dreams you had given up on.” Among these, regenerative medicine utilizing stem cells treats diseases by harnessing the repair capabilities of cells that can differentiate into various cell types and restore weakened areas.

Features of HORIE R.P Clinic

HORIE R.P Clinic is a medical institution that has followed the formal process, submitted a Type II Regenerative Medicine Provision Plan to the Ministry of Health, Labour and Welfare
, and obtained a plan number.

High-quality cell culture and management system

Using the highest quality cell culture technology, we maintain a cleanroom environment with a cell processing room at Class 1,000 and a bioclean bench (cell culture workroom) at Class 100. We administer stem cells at our clinic via refrigerated transport, ensuring nearly 100% viability by administering them within 48 hours of culture completion. The average cell survival rate during actual transport at our clinic is 98.36%. (August 2024 - January 2025)

Cutting-edge culture technology through CPC integration

The key factor in autologous adipose-derived stem cell therapy is stem cell culture technology. Stem cell culture is performed in a CPC (Cell Processing Center), and administering live stem cells is expected to yield therapeutic effects. High survival rates directly correlate with the rate of engraftment within the body, and the process of selecting cells of a size that can smoothly traverse blood vessels is also crucial. The CPC affiliated with our clinic is a top-tier domestic facility with advanced technical capabilities.

Doctor Introduction

ドクター写真

Doctor of Medical Science, Board-Certified Specialist by the Japan Neurosurgical Society,

Orthopedic Surgery Dr. Takayuki Kato

Brief Biography

  • 1996.03Graduated from Kansai Medical University, School of Medicine
  • 1996.04Joined the Department of Neurosurgery, Kansai Medical University
  • 1998.04Entered the Graduate School of Kansai Medical University, Department of Neurosurgery
  • 2003.08Certified Specialist, Japan Neurosurgical Society
  • 2003.09Part-time Neurosurgeon, Tominaga Hospital

Primary Work History

  • Kansai Medical University Affiliated Otokoyama Hospital
  • Medical Corporation Sanseikai Kawachi General Hospital
  • Medical Corporation Ishiseikai Joto Central Hospital and others

Conditions Treated with Stem Cell Therapy
at Our Clinic

Cerebrovascular Disorders

Cerebrovascular Disorders

Osteoarthritis

Osteoarthritis

Chronic pain

Chronic pain

Selection Criteria for Target Diseases
in Regenerative Medicine

Regenerative medicine targets diseases such as cerebrovascular disorders, osteoarthritis, and chronic pain, where existing treatments fail to provide sufficient improvement. Among patients who wish to undergo this treatment, it will only be administered when the physician performing regenerative medicine determines, based on examination, that other treatments are unlikely to be effective and that this treatment is appropriate.

The Flow of Regenerative Medicine

Step

1

1

Inquiries (Appointment Requests)

Phone and Email Support

Step

2

2

Consultation with a Specialist Physician

Completion of a Medical Questionnaire

Step

3

3

Examination by a Specialist Physician(Various Diagnostic Tests)   

Medical Examination, Blood Testing, and Completion of Consent Forms (Signature Required)
Payment for Stem Cell Therapy

Step

4

4

Adipose Tissue Collection and Blood Sampling

Adipose tissue collection (approximately 5 g of adipose tissue is harvested from an inconspicuous area of the lower abdomen)
Blood collection required for cell culture

Step

5

5

Cultured at CPC (Cell Processing Center)

Cultivation period: Approximately 6 weeks
*Individual results may vary

Step

6

6

Administration Therapy

The administration date will be scheduled no earlier than six weeks after adipose tissue collection

Step

7

7

Subsequent administrations

Re-administer 1 to 4 weeks after the first treatment,
then every 4 weeks thereafter.

Step

8

8

Postoperative Assessment

After administration, monthly follow-up examinations will be conducted for six months

受話器アイコン 06-6543-1500
PAGE TOP